Background. Langerhans cell histiocytosis is an uncommon clonal disorder. i
ts reactional or genetic nature is debated.
Case report. Three patients aged 71, 75 and 71 years with Langerhans cell h
istiocytosis also developed myelomoncytic leukemia (AML(4), AML(5), and chr
onic myelomonocytic leukemia). In two cases, there was no prior treatment w
hich could potentially induce leukemia. In the third case, AML4 occurred sh
ortly (10 months) after initiation of a vinblastin treatment.
Discussion. This pathogenic association suggests a common origin for these
two conditions, corresponding to an anomalous pluripotent stem cell line. T
hese cases provide further evidence favoring the hypothesis of a genetic or
igin rather than a reactional origin for Langerhans cell histiocytosis.